Skip to main navigation
Tactile Medical
  • About Lymphedema
    • Overview
    • Signs & Symptoms
    • Treatment
    • Management
  • Products
    • Overview
    • FLEXITOUCH® system
    • Entre™ System
    • Actitouch® System
    • Clinical Evidence
  • Patients
    • Overview
    • Signs & Symptoms
    • Patient Testimonials
    • Lymphedema Partners
  • Healthcare Professionals
    • Overview
    • Virtual Learning
    • Clinician Perspectives
    • Health Plan Coverage
    • Veterans Affairs
    • Clinical Evidence
    • Professional Affiliations
    • Educational Resources
  • Investors
    • News
    • Events & Webcasts
    • Stock Information
    • Annual Reports & SEC Filings
    • Corporate Governance
    • Investor FAQs
    • Investor Contacts
  • About Us
    • Who We Are
    • Leadership
    • News
    • Careers
Patient Portal
Select Page

Investors

Investors

 
At Tactile Medical, a fundamental value is to earn a fair profit and return value for our shareholders

Data Provided by Refinitiv.
Minimum 15 minutes delayed.


Q3 2020 Investor Presentation

Download

2019 Annual Report to Stockholders

Download

Sign up for Email Alerts

Learn More

Upcoming Events

More events are coming soon.

Recent News

January 5, 2021
Tactile Medical Announces Additions to Board of Directors
Appointment of Sheri Dodd and Deepti Jain MINNEAPOLIS , Jan. 05, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced the
Read More »
January 5, 2021
Tactile Medical to Present at the ICR Conference 2021
MINNEAPOLIS , Jan. 05, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that management will participate in a fireside chat
Read More »
November 3, 2020
Tactile Medical to Participate in Upcoming Investor Conferences in November and December
MINNEAPOLIS , Nov. 03, 2020 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that management will participate in the following
Read More »
November 2, 2020
Tactile Systems Technology, Inc. Reports Third Quarter 2020 Financial Results; Provides Updated Full Year 2020 Outlook
Third Quarter Revenue Decreased 1% Year-Over-Year; Flat Year-Over-Year on an Operational Basis First Nine Months Revenue Decreased 3% Year-over-Year; Flat Year-over-Year on an Operational Basis MINNEAPOLIS , Nov. 02, 2020 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc.
Read More »
View All News »
  • RSS Feeds
  • Email Alerts
  • Investor Contacts
  • Print Page
  • E-mail Page
Logo


Tactile Systems Technology, Inc. BBB Business Review
  • About Lymphedema
  • Products
  • Patients
  • Healthcare Professionals
  • Investors
  • About Us
  • Careers
  • Pay My Bill
  • Educational Resources
  • Patient Contact Us
  • Clinician Contact Us
  • Forms
  • Media Resources
  • Privacy Statement
  • California Privacy Notice
  • Privacy Line: 833.382.2845 ext. 55211
  • Terms & Conditions
  • Warranty & Return Policies
3701 Wayzata Blvd, Suite 300
Minneapolis, MN 55416 USA

Phone: 612.355.5100
Toll-free: 866.435.3948
Fax: 866.435.3949
facebook linkedin twitter youTube
Flexitouch, Actitouch, Entre and HEALING RIGHT AT HOME are all trademarks or registered trademarks of Tactile Medical.
D/N500187-000-00 Rev. J 11/2017